2-Deoxyglucose

2-脱氧-D-葡萄糖

Report date: 2026/04/10 20:01:49
NME

Base Information

Drug Name2-Deoxyglucose
Drug Alias Name2-deoxy-D-glucose2-DG
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionGlycolysis inhibitorsVirus replication inhibitorsSerine/threonine-protein kinase DCLK1 inhibitors
TargetsSerine/threonine-protein kinase DCLK1
Therapy Area/IndicationsOverweightObesityInsulin Resistance +[15] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsAustria
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wisconsin-MadisonThreshold Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesColumbia UniversityUniversity Of Wisconsin-MadisonUniversity Of Virginia +[4] 
Inactive CompaniesThreshold PharmaceuticalsThe University Of IowaRutgers University
Active IndicationsOverweightObesityInsulin Resistance +[7] 
Inactive IndicationsNeoplasm MetastasisProstatic NeoplasmsLung Neoplasms +[8] 

Other Information

ATC CodeN/A
Related LinksN/A